Floatz logo

S-Ketamine

Dexmedetomidine

Peking University First HospitalPhase 4 / ApprovedActive
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
89/ 100

Competitive context

20 Active assets in the Dexmedetomidine cohort.

Asset / SponsorPhaseRating
Bxcl501
Peking University First Hospital
Phase 4BBB
Amitriptyline
Peking University First Hospital
Phase 4BB
Pregabalin
Peking University First Hospital
Phase 4BB
SUFENTANYL
Peking University First Hospital
Phase 4BB
Zofran
Peking University First Hospital
Phase 4BB

View all 21 →

Same molecule, other indications

S-Ketamine is also rated in:

depressive disorderDormant
A
Indicative ·
81 / 100
View asset →
major depressive disorderDormant
BBB
Indicative ·
76 / 100
View asset →
depressive disorderDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →